StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Neurocrine Biosciences, Inc.
NasdaqGS:NBIX
Sector
Location
Market Cap
USD 13.05 B
Share Price
USD 131.83
Avg Daily Volume
1,322,248
Change (1 day)
-0.14%
Change (1 year)
-9.51%
Change (YTD)
-3.42%
Neurocrine Biosciences, Inc. Accounts Payable for the year ending December 31, 2024: USD 110.00 M
Neurocrine Biosciences, Inc. Accounts Payable is USD 110.00 M for the year ending December 31, 2024, a 1.01% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
-
Neurocrine Biosciences, Inc. Accounts Payable for the year ending December 31, 2023 was USD 108.90 M, a 61.81% change year over year.
-
Neurocrine Biosciences, Inc. Accounts Payable for the year ending December 31, 2022 was USD 67.30 M, a 30.68% change year over year.
-
Neurocrine Biosciences, Inc. Accounts Payable for the year ending December 31, 2021 was USD 51.50 M, a 30.71% change year over year.
-
Neurocrine Biosciences, Inc. Accounts Payable for the year ending December 31, 2020 was USD 39.40 M, a -4.83% change year over year.
Competitors
Eli Lilly and Company
USD 762.18
LLY
-9.53
-1.23%
AbbVie Inc.
USD 184.85
ABBV
-4.41
-2.33%
Novo Nordisk A/S
USD 64.18
NOVO-B.CO
-0.20
-0.32%
Roche Holding AG
USD 338.18
RO.SW
-2.81
-0.82%
Novartis AG
USD 114.67
NOVN.SW
-0.44
-0.38%
Abbott Laboratories
USD 124.42
ABT
+0.75
0.61%
AstraZeneca PLC
USD 138.01
AZN.L
-0.01
-0.01%
Merck & Co., Inc.
USD 79.31
MRK
-0.65
-0.81%
Amgen Inc.
USD 295.87
AMGN
+1.11
0.38%
Pfizer Inc.
USD 24.26
PFE
-0.21
-0.86%
Gilead Sciences, Inc.
USD 108.28
GILD
+0.06
0.06%
Vertex Pharmaceuticals Incorporated
USD 458.49
VRTX
-1.32
-0.29%
Sanofi
USD 96.20
SAN.PA
-0.42
-0.44%
Bristol-Myers Squibb Company
USD 46.69
BMY
-0.67
-1.42%
CSL Limited
USD 166.56
CSL.AX
-0.83
-0.50%
Chugai Pharmaceutical Co., Ltd.
USD 46.18
4519.T
-0.87
-1.84%
GSK plc
USD 18.13
GSK.L
+0.05
0.30%
Regeneron Pharmaceuticals, Inc.
USD 545.53
REGN
+3.01
0.56%
Cencora, Inc.
USD 292.67
COR
-0.20
-0.07%
MERCK Kommanditgesellschaft auf Aktien
USD 128.35
MRK.DE
-0.23
-0.18%
Key Data
| Date | Accounts Payable | Short-Term Debt | Long-Term Debt | Total Liabilities |
|---|
Competitors
Eli Lilly and Company
USD 762.18
LLY
-9.53
-1.23%
AbbVie Inc.
USD 184.85
ABBV
-4.41
-2.33%
Novo Nordisk A/S
USD 64.18
NOVO-B.CO
-0.20
-0.32%
Roche Holding AG
USD 338.18
RO.SW
-2.81
-0.82%
Novartis AG
USD 114.67
NOVN.SW
-0.44
-0.38%
Abbott Laboratories
USD 124.42
ABT
+0.75
0.61%
AstraZeneca PLC
USD 138.01
AZN.L
-0.01
-0.01%
Merck & Co., Inc.
USD 79.31
MRK
-0.65
-0.81%
Amgen Inc.
USD 295.87
AMGN
+1.11
0.38%
Pfizer Inc.
USD 24.26
PFE
-0.21
-0.86%
Gilead Sciences, Inc.
USD 108.28
GILD
+0.06
0.06%
Vertex Pharmaceuticals Incorporated
USD 458.49
VRTX
-1.32
-0.29%
Sanofi
USD 96.20
SAN.PA
-0.42
-0.44%
Bristol-Myers Squibb Company
USD 46.69
BMY
-0.67
-1.42%
CSL Limited
USD 166.56
CSL.AX
-0.83
-0.50%
Chugai Pharmaceutical Co., Ltd.
USD 46.18
4519.T
-0.87
-1.84%
GSK plc
USD 18.13
GSK.L
+0.05
0.30%
Regeneron Pharmaceuticals, Inc.
USD 545.53
REGN
+3.01
0.56%
Cencora, Inc.
USD 292.67
COR
-0.20
-0.07%
MERCK Kommanditgesellschaft auf Aktien
USD 128.35
MRK.DE
-0.23
-0.18%